Back to Trades
BENEVICH ERIC
Chief Commercial OfficerCIK 0001643653
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 2
- Active
- 2025–2026
Across 7 filings between 2025–2026, BENEVICH ERIC, Chief Commercial Officer, has disclosed $9.6M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.2M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Sep 15 | NBIX NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Grant | $529.0K |
| Sep 10 | NBIX NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Sell | $333.0K |
| May 13 | ATYR aTYR PHARMA INC | BENEVICH ERIC | Insider | Award | $47.5K |
| Feb 17 | NBIX NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Grant | $6.0M |
| Feb 3 | NBIX NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Exercise | $175.8K |
| Jan 16 | NBIX NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Exercise | $923.5K |
| Dec 2 | NBIX NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | Sell | $905.9K |
7 filings